Abstract
Purpose of Review
This review examines the diverse functional relationships that exist between the peripheral nervous system (PNS) and bone, including key advances over the past century that inform our efforts to translate these discoveries for skeletal repair.
Recent Findings
The innervation of the bone during development, homeostasis, and regeneration is highly patterned. Consistent with this, there have been nearly 100 studies over the past century that have used denervation approaches to isolate the effects of the different branches of the PNS on the bone. Overall, a common theme of balance emerges whereby an orchestration of both local and systemic neural functions must align to promote optimal skeletal repair while limiting negative consequences such as pain.
Summary
An improved understanding of the functional bidirectional pathways linking the PNS and bone has important implications for skeletal development and regeneration. Clinical advances over the next century will necessitate a rigorous identification of the mechanisms underlying these effects that is cautious not to oversimplify the in vivo condition in diverse states of health and disease.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The skeleton and the peripheral nervous system (PNS) are not independent. Instead, there is a continuous bidirectional relationship across both that facilitates optimal function [1]. This can include direct, local actions of nerves on bone cells or delivery of circulating neurotransmitters through the bloodstream (Fig. 1(A), (B)). Conversely, secreted factors from skeletal cells and biomechanical signals can modulate bone-to-brain interoceptive pathways and global peripheral nerve function. Beyond this, there are many layers of possible regulation. For example, neural signals in distant organ systems such as the gut, pancreas, or liver can regulate the bone through the modulation of circulating and humoral factors [2]. PNS function can also modify the immune response. In addition, changes in peripheral nerve function can alter muscle, behavior, and movement, resulting in local adaptation of the bone due to altered biomechanical loading [3]. Though complex, these broad potential relationships between the PNS and bone present a unique opportunity for discovery. Indeed, it has become increasingly clear that an improved understanding of neural signaling pathways has important implications for skeletal development and regeneration. In this review, we will first provide an overview of the peripheral innervation of the bone during development and repair. Next, we will comprehensively summarize the outcomes from denervation experiments performed since the 1900s that inform our understanding of the in vivo relationships between the PNS and bone. Last, we will discuss the developing clinical implications and applications for PNS pathways in skeletal regeneration.
Innervation and regulation of the bone by the peripheral nervous system (PNS). (A) Three pathways of regulation of the bone by the PNS: (1) network effects, where all four divisions of the PNS indirectly influence the bone via their actions on diverse organ systems (represented by a liver icon) and downstream circulating factors (blood vessel icon); (2) indirect effects via circulation, where the sensory, parasympathetic, and sympathetic divisions of the PNS influence the bone by secreting neurotransmitters into the bloodstream; and (3) direct innervation of the bone, where only the sensory and sympathetic divisions directly release signals into the local bone microenvironment. Solid lines represent direct innervation, and dotted lines represent subsequent indirect effects mediated by circulating factors. (B) Direct innervation of bone structures by the sensory and sympathetic divisions of the PNS. The colored lines originating from (A) continue into this figure as nerve fibers from the sensory (pink) and sympathetic (green) divisions. This figure provides a deconstructed view of a bone, with the periosteum being pulled away from the surface and the bone sliced to expose the marrow and vessels within. Multiple call-out boxes elucidate the interactions of these nerve fibers with various bone structures. The colored circles near the nerve endings represent neurotransmitters secreted by these nerve fibers in response to local molecular, chemical (e.g., H +), and mechanical signals
Innervation of the Bone from Development to Regeneration
Coordinated Neural Infiltration Occurs During Skeletal Development
The bone contains a widely distributed neurovascular system that includes both sensory and sympathetic nerve fibers [4•, 5, 6, 7•, 8, 9••, 10••] (Fig. 1). By contrast, the bone is not directly innervated by the motor or parasympathetic divisions of the PNS (reviewed in [11]). This well-defined pattern of skeletal innervation is established during development and is highly conserved between vertebrate species [8, 12, 13]. Axons extend from the central nervous system (CNS) to peripheral targets during gestation (day 9 to day 13 in mouse) [14]. Consistent with this, in rats, the first signs of sensory innervation of the limb skeleton have been detected in the perichondrial tissue at gestational day 15 and within the bone organ at neonatal day 4 [8, 12]. This matches the infiltration of tropomyosin receptor kinase A (TrkA) expressing sensory nerves at the primary ossification centers at gestational day 14.5 in mice primarily in response to nerve growth factor (NGF) expression by the perichondrial cells [13]. Overall, nerves and blood vessels infiltrate simultaneously in areas with high osteogenic and chondrogenic activities close to the growth plate, with sensory nerves infiltrating during gestation, approximately 10 days before the postnatal recruitment of sympathetic autonomic axons [8]. This neuronal temporal delay is synchronized with the mineralization of the primary ossification centers [8, 12]. The early presence of sensory and sympathetic nerve fibers is similarly seen during intramembranous bone development in neonatal periods [15, 16].
After development, the innervation of the mature skeleton takes on several key features. First, the highest innervation density is in the periosteum, followed by the bone marrow and cortical bone [4•, 5, 6, 7•, 9••] (Fig. 1). While sensory nerves predominate in the periosteum, this is reversed to favor sympathetic axons within the bone marrow. There is also evidence of regional variation, for example, with the thoracic vertebra having higher levels of sensory innervation than the neurocranium [7•]. Second, consistent with their vasoregulatory role, most nerves in and on the bone are closely associated with the arteriolar vascular network (> 95% in the bone/marrow; ~ 80% in periosteum) [4•, 6, 11]. In humans, this means that nerve fibers are widely distributed with arterioles throughout the Haversian canal system, and in smaller species such as rodents, nerves run with nutrient arteries through transcortical canals to enter the bone marrow. By contrast, venous sinusoids in the bone and elsewhere throughout the body are not innervated. There are also many regions of the bone and bone marrow that are relatively or completely aneural. The endosteum, for example, is essentially devoid of innervation [4•, 6]. Third, there are no nerve cell bodies or true synapses in the bone. Nerve cell bodies are located in the ganglia at the level of the spinal cord (or corresponding craniofacial ganglia) [11]. Sensory and sympathetic nerves then target the bone through unipolar axonal extensions, referred to as free nerve endings because they do not synapse with other cells. Instead, they exist locally within the environment and, depending on the nerve type, relay information to the CNS based on local changes in pressure, ions, metabolites, and/or soluble factors [11, 17, 18]. Conversely, axons in bone signal to surrounding cells through the bulk release of neurotransmitters and neuropeptides. Additional information about neuronal subtypes, targeting, and function is beyond the scope of this review but has been discussed elsewhere [11, 17,18,19,20].
The Skeletal Neural Network Undergoes Active Remodeling During Bone Regeneration and Repair
Neural infiltration following skeletal injury is a well-described phenomenon that contributes to pain [21,22,23] but may also be important for adequate healing. Secreted nerve recruitment factors termed neurotrophins are found throughout regions of bone regeneration with expression from diverse neural and non-neural cell types, including osteolineage cells, chondrocytes, macrophages, osteoclasts, and vascular cells [13, 24, 25, 26•, 27, 28]. Neurotrophins promote axonal growth into the injured site and, in some cases, may also act directly on local skeletal or endothelial cells to promote osteogenesis and angiogenesis, respectively [28,29,30]. Expression of the neurotrophin NGF, a TrkA receptor agonist, is driven by inflammatory signals such as interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNFα) that rapidly upregulate its local expression, which peaks approximately 3 days after acute bone injury [26•, 27, 28]. Recent studies also convincingly demonstrate that NGF binding to neural TrkA is the main stimulus for nerve ingrowth during skeletal regeneration [24, 26•, 27]. This is consistent with the expression of TrkA on ~ 80% of sensory and ~ 100% of sympathetic nerves in the bone [5]. Expression of the TrkC agonist, neurotrophin-3 (NT-3), follows a similar pattern after fracture, while the TrkB agonist, brain-derived neurotrophic factor (BDNF), remains elevated throughout healing [28]. In distraction osteogenesis, which provides a model to explore both endochondral and intramembranous ossification, NGF and TrkA are expressed highly during the distraction phase, while BDNF, NT-3, TrkB, and TrkC are upregulated during the consolidation phase. Chemoattractants and chemorepellants also direct the projections taken by the axonal growth cones, in addition to acting locally to regulate skeletal cells. This includes galanin, netrins, semaphorins, neuropilins, and ephrins, many of which have emerging roles in bone homeostasis and repair [31,32,33,34]. Many neuroregulatory factors can also directly stimulate angiogenesis, reinforcing the close coupling between nerve recruitment, vascularization, and healing [30, 35, 36].
Local nerve sprouting after injury expands the web of axons in the bone without changing the overall number of neurons in the CNS. This may have functional consequences for the interpolation of nearby signals through central relays and can also substantially modify the local release of neurotransmitters. After a fracture, sensory axons rapidly infiltrate the callus and periosteum with maximal innervation reported between days 1 and 7 after injury, prior to gradual regression during consolidation and healing [21, 27, 37,38,39,40]. Infiltration of nerves occurs even prior to blood vessels in some circumstances [27, 39]. Recruitment of sympathetic nerves after injury coincides with sensory peptidergic axons, likely due to the shared expression of TrkA and response to NGF by both axon subtypes [27, 38, 41]. In angular fractures, a unique tibial fracture model with site-specific changes in bone healing, sensory and sympathetic axon density is significantly higher along the concave side of the fracture site rather than the convex side, coinciding with regions of higher bone formation [37, 38]. This suggests that early neural (and perhaps combined neurovascular) infiltration may be vital to promote adequate bone formation. By contrast, in non-healing fractures, one study in humans found a lack of innervation, while another study identified neuroma-like structures in mice [42, 43]. Persistent innervation likely contributes to sustained pain responses [21, 22, 43]. However, it is unclear whether nerves that are generally suspected to play a positive role in early regeneration may also function to inhibit healing when they persist.
Neural Contributions to Bone Homeostasis and Regeneration—Positive, Negative, Neutral, or All of the Above?
Since the 1800s, there have been nearly 100 studies that have used denervation approaches to isolate the effects of the different branches of the PNS on bone development, homeostasis, and repair (Fig. 2). These results are summarized below, and 65 key experiments across 51 manuscripts from 1900–2023 are presented in Table 1.
Effects of peripheral denervation on bone development, homeostasis, and repair. This figure illustrates the key methods and outcomes of 65 denervation experiments from 1900–2023, as detailed in Table 1. The schematic features a section of the spinal cord with sensory (pink), sympathetic (green), and motor (yellow) nerve fibers extending to a long bone, with accompanying muscle and vasculature. Seven boxes, each color-coded to the relevant nerve type, detail specific types of interventions and their collective outcomes. Icons within the boxes represent the method of denervation: a scalpel for surgical cuts, forceps for the removal of nervous tissue, and syringes for chemical/genetic denervation. The outcomes of these interventions are summarized by colored gradient bars (green for positive effects on the bone, yellow for neutral, and red for negative), reflecting the proportion of experimental studies yielding the indicated results. Additional icons highlight specific outcomes: artery with an upward arrow indicates increased blood flow, cracked bone signifies poor fracture healing, bone with a downward arrow represents bone loss, and muscle with a downward arrow indicates muscle loss
Mixed Denervation Approaches Reinforce the Link Between the Muscle and Bone and Provide New Clues About Neural Coordination of Soft and Hard Tissue Healing
Sir D’Arcy Thompson in 1917 said, “Between muscle and bone there can be no change in the one but it is correlated with changes in the other” [44]. The same remains true within the context of the neural regulation of the bone. Specifically, any reduction of the motor innervation of muscle will subsequently lead to progressive skeletal atrophy due to loss of muscle mass. This is most clearly shown after the transection of the ventral motor roots of the spinal cord to induce selective motor denervation of the limb [45, 46•] and has since been repeated many times in studies of peripheral nerve resection. This most commonly includes the brachial plexus (upper limb), sciatic and femoral nerves (lower limb), and inferior alveolar nerve (mandible) that contain mixed populations of motor, sensory, and sympathetic axons [47,48,49,50,51,52,53,54,55,56,57,58,59]. In 12/14 studies in Table 1, when mixed surgical denervation was paired with models of bone injury, denervation had a negative impact on soft tissue closure, fracture repair, or osseous defect healing.
Mixed peripheral nerve function has also been studied within the context of axolotl limb regeneration. Axolotls are capable of full limb re-growth when amputation is performed proximal to the elbow joint. Local expression of neuregulin-1 and its receptor, ErbB2, are decreased with limb denervation [60]. In addition, denervation delays regeneration, while supplementation of neuregulin-1 rescues regeneration in denervated limbs. The closest analog to this in mammals is the regeneration of the terminal portion of the digit tip. Sensory and sympathetic nerves are found in the digit tip prior to and during regeneration [61••]. However, despite work suggesting that nerves are required for complete renewal [62], a recent study found that nerves are exclusively required for soft tissue wound closure rather than bone regeneration. Thus, when open wounds were treated with Dermabond to stimulate closure, regenerated digits with denervation were morphologically similar to controls [63]. Overall, mixed denervation approaches demonstrate that an intact PNS supports optimal regeneration when present. In addition to maintaining muscle mass, this work also hints at mechanisms that may include the neural regulation of both hard and soft tissue healing.
Studies of Surgical, but Not Chemical, Denervation Show that Depletion of Sympathetic Nerves May Promote Bone Accrual and Repair by Increasing Blood Flow
In the early 1900s, an extensive series of experiments were undertaken to understand the impact of surgical sympathetic denervation on bone development and fracture healing (Fig. 2, Table 1). The rationale was the finding that sympathetic denervation could promote local vascularization and blood flow. The first surgical method consisted of the removal of the sympathetic ganglia (e.g., unilateral lumbar gangliotomy to denervate the lower limb). This results in permanent and selective removal of the sympathetic nerves in a small body region. Fracture or bone defect healing with sympathetic gangliotomy showed either no change [64,65,66,67,68] or increased healing on the sympathectomized side [67, 69,70,71]. Unilateral lumbar sympathectomy was also performed in 46 children with leg paralysis and unilateral shortening due to poliomyelitis, to increase the growth of the affected limb [72]. Despite failed experiments in kittens, puppies, and lambs that showed no difference in limb growth, there was an acceleration or maintenance of the rate of growth of the paralyzed leg on the sympathectomized side in 63% of cases. The second approach, termed periarterial sympathectomy, consisted of the removal of the sympathetic nerve axon-containing adventitia from the vessel wall (e.g., the femoral artery for the lower limb). This causes sympathetic denervation of the vessel itself and any downstream site that was originally targeted by this vascular network. Overall, periarterial sympathectomy resulted in increased blood flow with more rapid callus formation, ossification, and healing on the sympathectomized side in dogs, rabbits, and humans [71, 73, 74]. However, despite some apparent clinical success, these procedures received substantial pushback from other members of the medical community that did not find them to be advantageous, and surgical sympathectomy has since been discontinued for growth- or fracture-related outcomes.
In contrast to the generally positive results of surgical sympathectomy, chemical sympathectomy often leads to bone loss, impaired bone strength, and impaired bone healing (Fig. 2, Table 1) [75,76,77,78,79,80,81]. The discrepancy between the surgical and chemical denervation models may be due to the whole-body suppression of sympathetic adrenergic systems by chemical treatment, resulting in substantial global alterations in mouse health that are not present after regional surgical denervation.
Sensory Nerves are Required to Ensure Optimal Skeletal Loading and May Augment Bone Formation and Repair in Settings of Development and Injury
Surgical studies have also been performed to selectively disrupt the sensory innervation of the bone (Table 1). Interpretation is challenging because sensory denervation causes improper limb use and joint trauma due to altered position sense. However, when isolated from changes in biomechanics and loading, surgical sensory denervation generally does not alter bone mass or strength over long periods of time (up to 3 years in one study) [45, 46•, 66, 82,83,84]. In the 1930s, this led to the conclusion that skeletal sensory innervation is not necessary for the maintenance of bone. However, more recently, sensory nerves have gained renewed attention based on their extensive pattern of infiltration following bone injury. Though some studies have shown neutral effects, chemical and genetic denervation studies have generally found that local sensory denervation during bone healing impairs implant osseointegration, alters fracture callus size, and decreases bone repair [23, 85,86,87]. Whole-body chemical and genetic methods of sensory denervation also lead to generalized bone loss in the absence of injury [85, 88,89,90,91]. As with chemical sympathetic denervation, differences between surgical and genetic/chemical approaches may be due to the impact of global sensory denervation on peripheral systems (sight, smell, gait, etc.), in addition to any local effects. In addition, any benefits of sensory nerve recruitment for fracture repair must be balanced with clinical needs. Management of fractures is challenging, particularly in patients with multiple co-morbidities, limited mobility, and pain. Currently, local sensory neurolysis is a clinically approved adjunct to manage pain for inoperable hip fractures [92•, 93]. Neurolysis substantially improves mobility and quality of life, which can also independently promote positive clinical outcomes for these patients.
Clinical Adaptation of Peripheral Neural Pathways for Skeletal Regeneration
The PNS mediates a multitude of critical functions throughout the body, and denervation studies over the last century show that gross modification to the PNS is generally not warranted to promote bone repair. However, the isolation of novel molecular mechanisms linking the PNS and bone has also led to the identification of several high-yield pathways that inform targeted strategies to support skeletal regeneration.
Methods to Enhance Nerve Infiltration Are Associated with Increased Bone Healing
With sensory denervation often resulting in impaired bone healing after injury (Table 1), therapeutic studies have aimed to promote neural ingrowth and, by proxy, encourage bone formation. Nerves and vessels infiltrate within the first week following a fracture. Thus, therapeutic methods aim to improve neurovascular infiltration early in the healing process. One study utilized MMP-degradable tissue-engineered periosteum (MMP-TEP)-coated allografts to improve scaffold integration with the native tissue since periosteum can help direct neurovascular infiltration [94]. The MMP-TEP allograft group demonstrated early-stage neurovascularization and improved both mineralization and mechanical properties of femoral defects as compared to hydrogel-TEP allografts and allografts alone. An additional group of studies has aimed to encourage bone formation by redirecting the entire nerve bundles to the injury region to improve neural infiltration and neuropeptide release during healing. Positioning the cut end of the peripheral nerve trunk into tissue-engineered bone grafts (TEBGs) improved callus and bone formation compared to TEBG-only samples [95,96,97,98]. In addition, nerve bundle TEBGs increased the expression of neuropeptides and their receptors and improved vascularization in the defect region. The mechanisms involved in this model were not explored in depth; however, the implanted nerve bundles may either be supporting innervation/neuropeptide production or perhaps serving as a reservoir of pro-regenerative signals from nerve-associated cells.
Sensory Neurotransmitter Calcitonin Gene–Related Peptide (CGRP) Can Enhance Bone Repair
One possible osteoanabolic factor is the sensory neurotransmitter CGRP. In addition to being a potent vasodilator, in vivo and in vitro studies report that CGRP promotes osteoblast differentiation and inhibits bone resorption [99]. CGRP receptor deletion in osteoprogenitors during fracture healing decreases callus and cartilage area as well as cell proliferation, resulting in an overall impairment to fracture healing [100]. Conversely, methods that increase the concentration of CGRP within skeletal defects can enhance the rate of bone formation and repair [99, 101]. For example, atypical femoral fractures, which exhibit delayed healing and can occur following bisphosphonate treatment, demonstrate lower CGRP expression, reduced bony bridging, and increased fibrous tissue formation. Local injection of CGRP (100 nM) for 14 days after injury helped to restore healing in these fractures [102••].
While exogenous neuropeptide delivery can enhance regeneration, high levels are often required. To avoid this, other therapeutic approaches aim to stimulate endogenous release by exploiting materials or systems that encourage neuronal signaling or neuropeptide expression. For example, biomaterials containing divalent metal cations such as magnesium induce local CGRP release and stimulate robust periosteum-derived stem cell osteogenic differentiation [102••, 103, 104••]. Direct stimulation of sensory nerve cell bodies in the dorsal root ganglia with an implanted microelectrical stimulation system (IMESS) also enhances CGRP production and drives spinal fusion only in IMESS-targeted areas. Similarly, in osteoporotic femoral fracture healing, IMESS at the dorsal root ganglia (20 min/day for 2 weeks) improves vascularization and fracture healing in a CGRP-dependent manner without increasing pain-like responses [105••]. Conversely, the intraperitoneal injection of CGRP inhibitors in rats negatively affected fracture healing, demonstrating a significant decrease in the formation of the mineralized callus [106]. Balancing the osteoanabolic effects of sensory neurotransmitters such as CGRP with pain outcomes is crucial since these factors can also enhance nociception [107]. Adding to the complexity, CGRP inhibitors such as atogepant and erenumab are used clinically for the treatment of migraine [108]. Development of pro-regenerative paradigms will require careful consideration of current therapeutics and the actions of target neurotransmitters across systems.
Schwann Cell–Secreted Factors Signal Bone-Forming Cells to Activate Repair Responses
Peripheral nerve axons are wrapped by a protective sheath of myelinating or non-myelinating Schwann cells. After an injury, certain populations of Schwann cells can disassociate from damaged axons to expand at the site of injury. Schwann cells primarily modulate bone regeneration through secreted factors that signal bone-forming cells. In mouse digit tip regeneration, denervation inhibited Schwann cell infiltration, depleting Schwann cell–secreted factors, including OSM and PDGF-AA, and inhibiting regeneration [109]. Transplantation of additional Schwann cells or local injection of OSM and PDGF-AA was able to rescue the impaired healing [109]. Schwann cell–derived exosomes were also shown to enhance osteogenic differentiation in vitro and improve bone formation in vivo when included in a titanium alloy scaffold [110]. Similarly, when Schwann cells were included in scaffolds along with osteoblasts and endothelial cells, angiogenesis and vascularization were enhanced in vivo [111]. Mechanistically, in vitro studies suggest that Schwann cell–derived factors increase the proliferation of skeletal stem cells and endothelial cells while signaling through the VEGF, ERK/MAPK, and PI3k-Akt pathways [112].
β-Blockers Increase BMD, Reduce Fracture Risk, and Promote Healing
Surgical denervation studies pinpoint the sympathetic nervous system as a negative regulator of bone (Fig. 2, Table 1). Consistent with this, norepinephrine, the primary neurotransmitter of sympathetic adrenergic axons, can act on skeletal β-adrenergic receptors to suppress bone formation and increase osteoclast function, leading to decreased bone mass [113,114,115]. This informs studies on the effects of β-blockers, a group of common antihypertensive medications, on bone homeostasis and repair. β-blockers inhibit the diverse effects of the neural- and adrenal-derived catecholamines, including norepinephrine. Clinical use of β-blockers is associated with reduced risk of fracture and increased bone mineral density [116,117,118]. Treatment with β-blockers in mouse models increases bone mass due to enhanced bone formation and decreased bone resorption [114]. The β-blocker propranolol can also promote mineral apposition, callus formation, and strength in rodent femoral defects [119]. Though it is unclear if the benefits to the bone are due to direct actions on bone cells (vs. vasoregulatory or other effects), β-blockers remain a promising therapeutic strategy for managing osteoporosis and enhancing bone healing. In addition, recent studies have identified alternate pathways that converge on the regulation of sympathetic tone to modulate bone mass. For example, genetic downregulation of PGE2 signaling by advillin-expressing sympathetic and sensory nerves or introducing divalent cations such as magnesium can suppress sympathetic activity, promoting osteoblast formation and increases in the bone [85, 91, 104••, 120]. Increased sympathetic tone has also been proposed as a putative mechanism underlying bone loss and fragility in diseases including chronic heart failure [78] and impaired fracture repair with the use of medications such as SSRIs [121], providing targeted opportunities for future intervention.
Activation of NGF/TrkA Signaling Can Augment Bone Healing but Needs to be Balanced with Pain and Tumor-Promoting Responses
Therapeutic approaches using growth factors are popular for targeting known regeneration pathways, as they involve simple strategies to stimulate the host microenvironment. Consistent with this, local application of the neurotrophin NGF activates neuronal signaling, vascularization, and other bone resident cells that stimulate bone formation [30, 41, 122,123,124,125,126]. Genetic targeting approaches have shown that the bone anabolic effects are largely mediated by the activation of TrkA, the high-affinity receptor of NGF [26•, 27], with the potential for additional pro-regenerative actions of the low-affinity NGF receptor p75-NTR [127]. Specifically, when paired with rodent models of long bone fracture or calvarial defect, global inhibition of TrkA signaling reduces vascularization, osteoblastic activity, and ossification rate [26•, 27]. Conversely, treatment with synthetic TrkA agonist gambogic amide can promote angiogenesis and bone repair [128]. The mechanism underlying this effect remains to be clarified and may involve the activation of TrkA on neural, vascular, and/or local skeletal cells [30, 128]. Beyond this, targeted inhibition of p75-NTR in osteoblast precursors can restrict osteoprogenitor migration into the repair site [127]. Other nerve regulatory factors and neuropeptides such as BDNF, substance P, Sema3A, vasoactive intestinal peptide, and galanin have also been used to trigger bone healing and demonstrated similar results [70, 129,130,131,132,133,134,135,136].
NGF/TrkA signaling is also a major regulator of peripheral pain. Given this, clinical anti-NGF therapies to treat musculoskeletal pain are currently under development, and inhibition of NGF/TrkA signaling to treat fracture pain has been tested in rodents. In this case, anti-NGF and anti-TrkA antibodies successfully reduced pain behaviors without affecting fracture repair [137, 138]. In addition, NGF may also be relevant to tumorigenesis [139]. Many studies highlight the increase of NGF secretion and its receptors in the microenvironment of different cancer types [140]. For this reason, increasing attention is directed toward NGF and/or TrkA as a therapeutic target for effectively controlling tumor progression. Most recently, this includes the clinical use of an emerging class of TRK inhibitors to treat TRK fusion–positive cancers [141]. While TRK inhibitors have favorable overall safety, off-target adverse events, including weight gain, dizziness/ataxia, paraesthesias, and bone fracture, are occasionally observed [141, 142]. Future studies will be essential to understand the impact of the clinical modulation of TRK signaling on the bone microenvironment during the maintenance and healing phases.
Conclusions
Studies on the relationships between the PNS and bone initially peaked in the early 1900s. Over 100 years later, we have now uncovered diverse links between the PNS and the skeleton that occur during bone homeostasis, development, and repair. Overall, a common theme of balance emerges whereby an orchestration of both local and systemic neural functions must align to promote optimal repair while limiting negative consequences such as pain. Advances over the next century will necessitate a rigorous identification of the mechanisms underlying these effects that is cautious not to oversimplify the in vivo condition. Clinical use of sensory neurolysis, CGRP inhibitors, and TRK-targeting therapies will undoubtedly inform our understanding of their necessity for bone health and the potential to leverage the anabolic components of these pathways to promote regeneration. In addition, β-blockers and PNS-targeting bioactive implant materials represent emerging strategies to support repair.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Wan Q-Q, Qin W-P, Ma Y-X, Shen M-J, Li J, Zhang Z-B, et al. Crosstalk between bone and nerves within bone. Adv Sci (Weinh). 2021;8:2003390.
Maryanovich M, Takeishi S, Frenette PS. Neural regulation of bone and bone marrow. Cold Spring Harb Perspect Med. 2018;8(9):a031344. https://doi.org/10.1101/cshperspect.a031344.
Kacena MA, White FA. No pain, no gain: will migraine therapies increase bone loss and impair fracture healing? EBioMedicine. 2020;60: 103025.
• Lorenz MR, Brazill JM, Beeve AT, Shen I, Scheller EL. A neuroskeletal atlas: spatial mapping and contextualization of axon subtypes innervating the long bones of C3H and B6 mice. J Bone Miner Res. 2021;36:1012–25. This paper maps the sensory and sympathetic innervation of mouse long bone and provides full thickness reference atlases that relate patterns of innervation to the surrounding muscle. Three unique neuroskeletal niches within the periosteum are also defined.
Castañeda-Corral G, Jimenez-Andrade JM, Bloom AP, Taylor RN, Mantyh WG, Kaczmarska MJ, et al. The majority of myelinated and unmyelinated sensory nerve fibers that innervate bone express the tropomyosin receptor kinase A. Neuroscience. 2011;178:196–207.
Sayilekshmy M, Hansen RB, Delaissé J-M, Rolighed L, Andersen TL, Heegaard A-M. Innervation is higher above bone remodeling surfaces and in cortical pores in human bone: lessons from patients with primary hyperparathyroidism. Sci Rep. 2019;9:5361.
• Steverink JG, Oostinga D, van Tol FR, van Rijen MHP, Mackaaij C, Verlinde-Schellekens SAMW, et al. Sensory innervation of human bone: an immunohistochemical study to further understand bone pain. J Pain. 2021;22:1385–95. The authors aimed to quantify sensory nerve fiber density in different anatomical locations of human bones using immunohistochemistry and confocal microscopy. They reported that the distribution of the sensory nerve fibers varied across different bone locations; however, there was no difference across genders.
Sisask G, Silfverswärd CJ, Bjurholm A, Nilsson O. Ontogeny of sensory and autonomic nerves in the developing mouse skeleton. Auton Neurosci. 2013;177:237–43.
•• Thai J, Kyloh M, Travis L, Spencer NJ, Ivanusic JJ. Identifying spinal afferent (sensory) nerve endings that innervate the marrow cavity and periosteum using anterograde tracing. J Comp Neurol. 2020;528:1903–16. This paper uses a unique approach to trace nerves from the dorsal root ganglia to the bone. This provides an unbiased identification of sensory nerve subtypes in skeletal tissues and shows that the unique TH+ sensory afferent population is not present in bone.
•• Utagawa K, Shin T, Yamada H, Ochi H, Sunamura S, Unno A, et al. Three-dimensional visualization of neural networks inside bone by Osteo-DISCO protocol and alteration of bone remodeling by surgical nerve ablation. Sci Rep. 2023;13:4674. This paperuses tissue clearing techniques to provide a beautiful view of the relatively sparse neural network in the whole bone marrow, which is otherwise difficult to appreciate using sectioning-based techniques. It also explores the role of ultra-local surgical denervation on bone homeostasis.
Brazill JM, Beeve AT, Craft CS, Ivanusic JJ, Scheller EL. Nerves in bone: evolving concepts in pain and anabolism. J Bone Miner Res. 2019;34:1393–406.
Sisask G, Bjurholm A, Ahmed M, Kreicbergs A. Ontogeny of sensory nerves in the developing skeleton. Anat Rec. 1995;243:234–40.
Tomlinson RE, Li Z, Zhang Q, Goh BC, Li Z, Thorek DLJ, et al. NGF-TrkA signaling by sensory nerves coordinates the vascularization and ossification of developing endochondral bone. Cell Rep. 2016;16:2723–35.
Wang L, Mongera A, Bonanomi D, Cyganek L, Pfaff SL, Nüsslein-Volhard C, et al. A conserved axon type hierarchy governing peripheral nerve assembly. Development. 2014;141:1875–83.
Kosaras B, Jakubowski M, Kainz V, Burstein R. Sensory innervation of the calvarial bones of the mouse. J Comp Neurol. 2009;515:331–48.
Alberius P, Skagerberg G. Adrenergic innervation of the calvarium of the neonatal rat. Its relationship to the sagittal suture and developing parietal bones. Anat Embryol. 1990;182:493–8.
Nencini S, Ivanusic JJ. The physiology of bone pain. How much do we really know? Front Physiol. 2016;7:157.
Mantyh PW. Mechanisms that drive bone pain across the lifespan. Br J Clin Pharmacol. 2019;85:1103–13.
Zeisel A, Hochgerner H, Lönnerberg P, Johnsson A, Memic F, van der Zwan J, et al. Molecular architecture of the mouse nervous system. Cell. 2018;174:999-1014.e22.
Usoskin D, Furlan A, Islam S, Abdo H, Lönnerberg P, Lou D, et al. Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing. Nat Neurosci. 2015;18:145–53.
Yasui M, Shiraishi Y, Ozaki N, Hayashi K, Hori K, Ichiyanagi M, et al. Nerve growth factor and associated nerve sprouting contribute to local mechanical hyperalgesia in a rat model of bone injury. Eur J Pain. 2012;16:953–65.
Mitchell SAT, Majuta LA, Mantyh PW. New insights in understanding and treating bone fracture pain. Curr Osteoporos Rep. 2018;16:325–32.
Jimenez-Andrade JM, Bloom AP, Mantyh WG, Koewler NJ, Freeman KT, Delong D, et al. Capsaicin-sensitive sensory nerve fibers contribute to the generation and maintenance of skeletal fracture pain. Neuroscience. 2009;162:1244–54.
Lee S, Hwang C, Marini S, Tower RJ, Qin Q, Negri S, et al. NGF-TrkA signaling dictates neural ingrowth and aberrant osteochondral differentiation after soft tissue trauma. Nat Commun. 2021;12:4939.
Chartier SR, Mitchell SA, Majuta LA, Mantyh PW. Immunohistochemical localization of nerve growth factor, tropomyosin receptor kinase A, and p75 in the bone and articular cartilage of the mouse femur. Mol Pain. 2017;13:1744806917745465.
•Meyers CA, Lee S, Sono T, Xu J, Negri S, Tian Y, et al. A neurotrophic mechanism directs sensory nerve transit in cranial bone. Cell Rep. 2020;31:107696. Using a cranial defect model, the authors highlighted the role of NGF-expressing cells during intramembranous bone regeneration. The inhibition of the NGF signaling pathway negatively affected the re-innervation and skeletal healing.
Li Z, Meyers CA, Chang L, Lee S, Li Z, Tomlinson R, et al. Fracture repair requires TrkA signaling by skeletal sensory nerves. J Clin Invest. 2019;129:5137–50.
Asaumi K, Nakanishi T, Asahara H, Inoue H, Takigawa M. Expression of neurotrophins and their receptors (TRK) during fracture healing. Bone. 2000;26:625–33.
Aiga A, Asaumi K, Lee Y-J, Kadota H, Mitani S, Ozaki T, et al. Expression of neurotrophins and their receptors tropomyosin-related kinases (Trk) under tension-stress during distraction osteogenesis. Acta Med Okayama. 2006;60:267–77.
Cantarella G, Lempereur L, Presta M, Ribatti D, Lombardo G, Lazarovici P, et al. Nerve growth factor-endothelial cell interaction leads to angiogenesis in vitro and in vivo. FASEB J. 2002;16:1307–9.
Zhu S, Zhu J, Zhen G, Hu Y, An S, Li Y, et al. Subchondral bone osteoclasts induce sensory innervation and osteoarthritis pain. J Clin Invest. 2019;129:1076–93.
Kenan S, Onur ÖD, Solakoğlu S, Kotil T, Ramazanoğlu M, Çelik HH, et al. Investigation of the effects of semaphorin 3A on new bone formation in a rat calvarial defect model. J Craniomaxillofac Surg. 2019;47:473–83.
Tear G. Molecular cues that guide the development of neural connectivity. Essays Biochem. 1998;33:1–13.
McDonald AC, Schuijers JA, Shen P-J, Gundlach AL, Grills BL. Expression of galanin and galanin receptor-1 in normal bone and during fracture repair in the rat. Bone. 2003;33:788–97.
Park KW, Crouse D, Lee M, Karnik SK, Sorensen LK, Murphy KJ, et al. The axonal attractant netrin-1 is an angiogenic factor. Proc Natl Acad Sci USA. 2004;101:16210–5.
Zheng S, Li W, Xu M, Bai X, Zhou Z, Han J, et al. Calcitonin gene-related peptide promotes angiogenesis via AMP-activated protein kinase. Am J Physiol, Cell Physiol. 2010;299:C1485–92.
Li J, Kreicbergs A, Bergström J, Stark A, Ahmed M. Site-specific CGRP innervation coincides with bone formation during fracture healing and modeling: a study in rat angulated tibia. J Orthop Res. 2007;25:1204–12.
Long H, Ahmed M, Ackermann P, Stark A, Li J. Neuropeptide Y innervation during fracture healing and remodeling. A study of angulated tibial fractures in the rat. Acta Orthop. 2010;81:639–46.
Li J, Ahmad T, Spetea M, Ahmed M, Kreicbergs A. Bone reinnervation after fracture: a study in the rat. J Bone Miner Res. 2001;16:1505–10.
Hukkanen M, Konttinen YT, Santavirta S, Paavolainen P, Gu XH, Terenghi G, et al. Rapid proliferation of calcitonin gene-related peptide-immunoreactive nerves during healing of rat tibial fracture suggests neural involvement in bone growth and remodelling. Neuroscience. 1993;54:969–79.
Grills BL, Schuijers JA, Ward AR. Topical application of nerve growth factor improves fracture healing in rats. J Orthop Res. 1997;15:235–42.
Santavirta S, Konttinen YT, Nordström D, Mäkelä A, Sorsa T, Hukkanen M, et al. Immunologic studies of nonunited fractures. Acta Orthop. 1992;63:579–86.
Chartier SR, Thompson ML, Longo G, Fealk MN, Majuta LA, Mantyh PW. Exuberant sprouting of sensory and sympathetic nerve fibers in nonhealed bone fractures and the generation and maintenance of chronic skeletal pain. Pain. 2014;155:2323–36.
Thompson DW. On growth and form. UK, London: Cambridge University Press; 1917.
Grey EG, Carr GL. An experimental study of the factors responsible for noninfectious bone atrophy. Bull Johns Hopkins Hosp. 1915;26:381–5.
• Yang Y, Zhou J, Liang C, Xiao Q, Chen Y, Yu B. Effects of highly selective sensory/motor nerve injury on bone metabolism and bone remodeling in rats. J Musculoskelet Neuronal Interact. 2022;22:524–35. This paper performs selective denervation of sensory or motor roots (or both) in rats prior to analysis of changes in bone. This is notable given the precision of the surgeries and shows a progressive increase in osteoclast recruitment with different surgical approaches.
Madsen JE, Hukkanen M, Aune AK, Basran I, Møller JF, Polak JM, et al. Fracture healing and callus innervation after peripheral nerve resection in rats. Clin Orthop Relat Res. 1998;(351):230–40.
Chiego DJ, Singh IJ. Evaluation of the effects of sensory denervation on osteoblasts by 3H-proline autoradiography. Cell Tissue Res. 1981;217:569–76.
Xu Y, Xia M, Chen T, Yang Y, Fu G, Ji P, et al. Inferior alveolar nerve transection disturbs innate immune responses and bone healing after tooth extraction. Ann N Y Acad Sci. 2019;1448:52–64.
Cao J, Zhang S, Gupta A, Du Z, Lei D, Wang L, et al. Sensory nerves affect bone regeneration in rabbit mandibular distraction osteogenesis. Int J Med Sci. 2019;16:831–7.
Song D, Jiang X, Zhu S, Li W, Khadka A, Hu J. Denervation impairs bone regeneration during distraction osteogenesis in rabbit tibia lengthening. Acta Orthop. 2012;83:406–10.
Tevlin R, Griffin M, Chen K, Januszyk M, Guardino N, Spielman A, et al. Denervation during mandibular distraction osteogenesis results in impaired bone formation. Sci Rep. 2023;13:2097.
Zhang D, Zhang P, Wang Y, Han N, Tang C, Jiang B. The influence of brain injury or peripheral nerve injury on calcitonin gene-related peptide concentration variation and fractures healing process. Artif Cells Blood Substit Immobil Biotechnol. 2009;37:85–91.
Al-Harby SW, Samy MT, El Naggar MI, Al-Demagh SA, Nooreldin MA. Delayed healing of experiment fractures in the denervated limbs of dogs. Bahrain Med Bull. 1996;18:1.
Gkiatas I, Kostas-Agnantis I, Agathopoulos S, Papadopoulos D, Vekris M, Gelalis I, et al. The effect of peripheral nervous system in growing bone biomechanics. An experimental study. J Orthop. 2019;16:289–92.
Ma S, Li J, Guo Y, Huang Y, Chi X, Wei Y, et al. Three-dimensional radiographic and histological tracking of rat mandibular defect repair after inferior alveolar nerve axotomy. Arch Oral Biol. 2021;131: 105252.
Wu Q, Yang B, Cao C, Guang M, Gong P. Age-dependent impact of inferior alveolar nerve transection on mandibular bone metabolism and the underlying mechanisms. J Mol Histol. 2016;47:579–86.
Frymoyer JW, Pope MH. Fracture healing in the sciatically denervated rat. J Trauma. 1977;17:355–61.
Aro H. Effect of nerve injury on fracture healing. Callus formation studied in the rat. Acta Orthop Scand. 1985;56:233–7.
Farkas JE, Freitas PD, Bryant DM, Whited JL, Monaghan JR. Neuregulin-1 signaling is essential for nerve-dependent axolotl limb regeneration. Development. 2016;143:2724–31.
•• Dolan CP, Yan M, Zimmel K, Yang T-J, Leininger E, Dawson LA, et al. Axonal regrowth is impaired during digit tip regeneration in mice. Dev Biol. 2019;445:237–44. This paper clarifies prior literature to reveal that denervation of the digit tip impairs soft tissue wound closure but does not impair bone formation directly. When synthetic wound closure is achieved, bone regenerates normally even in the absence of innervation.
Storer MA, Miller FD. Cellular and molecular mechanisms that regulate mammalian digit tip regeneration. Open Biol. 2020;10: 200194.
Dolan CP, Imholt F, Yan M, Yang T-J, Gregory J, Qureshi O, et al. Digit specific denervation does not inhibit mouse digit tip regeneration. Dev Biol. 2022;486:71–80.
Key JA, Moore RM. Healing of fractures, of defects in bone and of defects in cartilage after sympathectomy. Arch Surg. 1933;26:272–9.
Kizilay H, Cakici H, Kilinc E, Firat T, Kuru T, Sahin AA. Effects of stellate ganglion block on healing of fractures induced in rats. Biomed Res Int. 2020;2020:4503463.
Corbin KB, Hinsey JC. Influence of the nervous system on bone and joints. Anat Rec. 1939;75:307–17.
Zollinger R. Effect of lumbar ganglionectomy upon repair of bone. Am J Surg. 1933;20:70–6.
Pearse HE, Morton JJ. The stimulation of bone growth by venous stasis. J. Bone Joint Surg. 1930;12:97.
Wang T, Cao J, Du Z, Zhang Y, Liu Y, Wang L, et al. Effects of sympathetic innervation loss on mandibular distraction osteogenesis. J Craniofac Surg. 2012;23:1524–8.
Du Z, Wang L, Zhao Y, Cao J, Wang T, Liu P, et al. Sympathetic denervation-induced MSC mobilization in distraction osteogenesis associates with inhibition of MSC migration and osteogenesis by norepinephrine/adrb3. PLoS ONE. 2014;9: e105976.
Ito H, Asami G. Lumbosacral sympathetic ganglionectomy its value as a therapeutic measure for thromboangiitis obliterans (with a sidelight upon alleged sympathetic innervation of the tonus of the skeletal muscles). Am J Surg. 1932;15:26–38.
Harris RI, Mcdonald JL. The effect of lumbar sympathectomy upon the growth of legs paralyzed by anterior poliomyelitis. J Bone Joint Surg. 1936
Colp R. Periarterial sympathectomy in fractures. Arch Surg. 1933;27:658.
Colp R. Experiences with periarterial sympathectomy in fractures of the lower extremity. JAMA. 1931;97:1069.
Shi L, Liu Y, Yang Z, Wu T, Lo HT, Xu J, et al. Vasoactive intestinal peptide promotes fracture healing in sympathectomized mice. Calcif Tissue Int. 2021;109:55–65.
Wagner JM, Wallner C, Becerikli M, Reinkemeier F, von Glinski M, Sogorski A, et al. Role of autonomous neuropathy in diabetic bone regeneration. Cells. 2022;11(4):612. https://doi.org/10.3390/cells11040612.
Scammell BE. A study of sympathectomy and fracture repair [Doctoral dissertation]. University of Southampton. United Kingdom. 1994.
Guan Z, Yuan W, Jia J, Zhang C, Zhu J, Huang J, et al. Bone mass loss in chronic heart failure is associated with sympathetic nerve activation. Bone. 2023;166: 116596.
Cherruau M, Facchinetti P, Baroukh B, Saffar JL. Chemical sympathectomy impairs bone resorption in rats: a role for the sympathetic system on bone metabolism. Bone. 1999;25:545–51.
Hill EL, Turner R, Elde R. Effects of neonatal sympathectomy and capsaicin treatment on bone remodeling in rats. Neuroscience. 1991;44:747–55.
Niedermair T, Straub RH, Brochhausen C, Grässel S. Impact of the sensory and sympathetic nervous system on fracture healing in ovariectomized mice. Int J Mol Sci. 2020;21(2):405. https://doi.org/10.3390/ijms21020405.
Eloesser L. On the nature of neuropathic affections of the joints. Ann Surg. 1917;66:201–7.
Corbin KB. Alterations in the hip joint after deafferentation. Arch Surg. 1937;35:1145.
Zhang Z-K, Guo X, Lao J, Qin Y-X. Effect of capsaicin-sensitive sensory neurons on bone architecture and mechanical properties in the rat hindlimb suspension model. J Orthop Translat. 2017;10:12–7.
Hu B, Lv X, Chen H, Xue P, Gao B, Wang X, et al. Sensory nerves regulate mesenchymal stromal cell lineage commitment by tuning sympathetic tones. J Clin Invest. 2020;130:3483–98.
Apel PJ, Crane D, Northam CN, Callahan M, Smith TL, Teasdall RD. Effect of selective sensory denervation on fracture-healing: an experimental study of rats. J Bone Joint Surg Am. 2009;91:2886–95.
Huang B, Ye J, Zeng X, Gong P. Effects of capsaicin-induced sensory denervation on early implant osseointegration in adult rats. R Soc Open Sci. 2019;6: 181082.
Offley SC, Guo T-Z, Wei T, Clark JD, Vogel H, Lindsey DP, et al. Capsaicin-sensitive sensory neurons contribute to the maintenance of trabecular bone integrity. J Bone Miner Res. 2005;20:257–67.
Ding Y, Arai M, Kondo H, Togari A. Effects of capsaicin-induced sensory denervation on bone metabolism in adult rats. Bone. 2010;46:1591–6.
Heffner MA, Anderson MJ, Yeh GC, Genetos DC, Christiansen BA. Altered bone development in a mouse model of peripheral sensory nerve inactivation. J Musculoskelet Neuronal Interact. 2014;14:1–9.
Chen H, Hu B, Lv X, Zhu S, Zhen G, Wan M, et al. Prostaglandin E2 mediates sensory nerve regulation of bone homeostasis. Nat Commun. 2019;10:181.
• Kwun-Tung Ng T, Chan W-S, Peng PWH, Sham P, Sasaki S, Tsui H-F. Chemical hip denervation for inoperable hip fracture. Anesth Analg. 2020;130:498–504. This paper highlights local denervation as an emerging technique to combat pain and limited mobility in patients with hip fracture. This highlights the fact that denervation may have important benefits to the patient that do not substantially impair local healing responses in humans.
Ng TK-T, Peng P, Chan W-S. Posterior hip pericapsular neurolysis (PHPN) for inoperable hip fracture: an adjunct to anterior hip pericapsular neurolysis. Reg Anesth Pain Med. 2021;46:1080–4.
Li Y, Hoffman MD, Benoit DSW. Matrix metalloproteinase (MMP)-degradable tissue engineered periosteum coordinates allograft healing via early stage recruitment and support of host neurovasculature. Biomaterials. 2021;268: 120535.
Fan J, Mu T, Qin J, Bi L, Pei G. Different effects of implanting sensory nerve or blood vessel on the vascularization, neurotization, and osteogenesis of tissue-engineered bone in vivo. Biomed Res Int. 2014;2014: 412570.
Chen S-Y, Qin J-J, Wang L, Mu T-W, Jin D, Jiang S, et al. Different effects of implanting vascular bundles and sensory nerve tracts on the expression of neuropeptide receptors in tissue-engineered bone in vivo. Biomed Mater. 2010;5: 055002.
Feng L, Lingling E, Liu H. The effects of separating inferior alveolar neurovascular bundles on osteogenesis of tissue-engineered bone and vascularization. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2015;159:637–41.
Wu Y, Jing D, Ouyang H, Li L, Zhai M, Li Y, et al. Pre-implanted sensory nerve could enhance the neurotization in tissue-engineered bone graft. Tissue Eng Part A. 2015;21:2241–9.
Xu J, Wang J, Chen X, Li Y, Mi J, Qin L. The effects of calcitonin gene-related peptide on bone homeostasis and regeneration. Curr Osteoporos Rep. 2020;18:621–32.
Wee NKY, Novak S, Ghosh D, Root SH, Dickerson IM, Kalajzic I. Inhibition of CGRP signaling impairs fracture healing in mice. J Orthop Res. 2023;41:1228–39.
Appelt J, Baranowsky A, Jahn D, Yorgan T, Köhli P, Otto E, et al. The neuropeptide calcitonin gene-related peptide alpha is essential for bone healing. EBioMedicine. 2020;59: 102970.
•• Zheng N, Xu J, Ruan YC, Chang L, Wang X, Yao H, et al. Magnesium facilitates the healing of atypical femoral fractures: a single-cell transcriptomic study. Mater Today. 2022;52:43–62. This paper uses single-cell RNA sequencing to identify the cell type responsible for irregular healing found in atypical femoral fractures. Furthermore, they showed that CGRP treatment, either through exogenous injection or through endogenous stimulation using a Mg intramedullary nail fixation system, could reduce the non-healing phenotype, demonstrating the key role of CGRP in fracture healing.
Zhang Y, Xu J, Ruan YC, Yu MK, O’Laughlin M, Wise H, et al. Implant-derived magnesium induces local neuronal production of CGRP to improve bone-fracture healing in rats. Nat Med. 2016;22:1160–9.
•• Qiao W, Pan D, Zheng Y, Wu S, Liu X, Chen Z, et al. Divalent metal cations stimulate skeleton interoception for new bone formation in mouse injury models. Nat Commun. 2022;13:535. This paper eloquently identifies the mechanism through which divalent cations found in bone implants stimulate bone healing. The authors propose a model whereby macrophages signal to CGRP+ nerves to send signals to the hypothalamus that downregulate sympathetic tone and encourage bone formation.
•• Mi J, Xu J-K, Yao Z, Yao H, Li Y, He X, et al. Implantable electrical stimulation at dorsal root ganglions accelerates osteoporotic fracture healing via calcitonin gene-related peptide. Adv Sci (Weinh). 2022;9: e2103005. This paper uses a unique approach to stimulate neuropeptide signaling through electrical stimulation in the dorsal root ganglia. Implantable electrical stimulation for 2 weeks following fracture enhanced CGRP secretion, type H vessel formation, and fracture healing.
Tang P, Duan C, Wang Z, Wang C, Meng G, Lin K, et al. NPY and CGRP inhibitor influence on ERK pathway and macrophage aggregation during fracture healing. Cell Physiol Biochem. 2017;41:1457–67.
Iyengar S, Ossipov MH, Johnson KW. The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine. Pain. 2017;158:543–59.
Mohanty D, Lippmann S. CGRP inhibitors for migraine. Innov Clin Neurosci. 2020;17:39–40.
Johnston APW, Yuzwa SA, Carr MJ, Mahmud N, Storer MA, Krause MP, et al. Dedifferentiated Schwann cell precursors secreting paracrine factors are required for regeneration of the mammalian digit tip. Cell Stem Cell. 2016;19:433–48.
Wu Z, Pu P, Su Z, Zhang X, Nie L, Chang Y. Schwann cell-derived exosomes promote bone regeneration and repair by enhancing the biological activity of porous Ti6Al4V scaffolds. Biochem Biophys Res Commun. 2020;531:559–65.
Zhang X, Jiang X, Jiang S, Cai X, Yu S, Pei G. Schwann cells promote prevascularization and osteogenesis of tissue-engineered bone via bone marrow mesenchymal stem cell-derived endothelial cells. Stem Cell Res Ther. 2021;12:382.
Zhang X, Xiong Q, Lin W, Wang Q, Zhang D, Xu R, et al. Schwann cells contribute to alveolar bone regeneration by promoting cell proliferation. J Bone Miner Res. 2023;38(1):119–30. https://doi.org/10.1002/jbmr.4735.
Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, et al. Leptin regulates bone formation via the sympathetic nervous system. Cell. 2002;111:305–17.
Treyball A, Bergeron AC, Brooks DJ, Langlais AL, Hashmi H, Nagano K, et al. Propranolol promotes bone formation and limits resorption through novel mechanisms during anabolic parathyroid hormone treatment in female C57BL/6J mice. J Bone Miner Res. 2022;37:954–71.
Khosla S, Drake MT, Volkman TL, Thicke BS, Achenbach SJ, Atkinson EJ, et al. Sympathetic β1-adrenergic signaling contributes to regulation of human bone metabolism. J Clin Invest. 2018;128:4832–42.
Schlienger RG, Kraenzlin ME, Jick SS, Meier CR. Use of beta-blockers and risk of fractures. JAMA. 2004;292:1326–32.
Turker S, Karatosun V, Gunal I. Beta-blockers increase bone mineral density. Clin Orthop Relat Res. 2006;443:73–4.
Lary CW, Hinton AC, Nevola KT, Shireman TI, Motyl KJ, Houseknecht KL, et al. Association of beta blocker use with bone mineral density in the Framingham Osteoporosis Study: a cross-sectional study. JBMR PLUS. 2020;4: e10388.
Minkowitz B, Boskey AL, Lane JM, Pearlman HS, Vigorita VJ. Effects of propranolol on bone metabolism in the rat. J Orthop Res. 1991;9:869–75.
Hunter DV, Smaila BD, Lopes DM, Takatoh J, Denk F, Ramer MS. Advillin is expressed in all adult neural crest-derived neurons. eNeuro. 2018;5(5). https://doi.org/10.1523/ENEURO.0077-18.2018.
Lee S, Remark LH, Buchalter DB, Josephson AM, Wong MZ, Litwa HP, et al. Propranolol reverses impaired fracture healing response observed with selective serotonin reuptake inhibitor treatment. J Bone Miner Res. 2020;35:932–41.
Wang L, Zhou S, Liu B, Lei D, Zhao Y, Lu C, et al. Locally applied nerve growth factor enhances bone consolidation in a rabbit model of mandibular distraction osteogenesis. J Orthop Res. 2006;24:2238–45.
Wang L, Cao J, Lei DL, Cheng XB, Zhou HZ, Hou R, et al. Application of nerve growth factor by gel increases formation of bone in mandibular distraction osteogenesis in rabbits. Br J Oral Maxillofac Surg. 2010;48:515–9.
Yan X-Z, Ge S-H, Sun Q-F, Guo H-M, Yang P-S. A pilot study evaluating the effect of recombinant human bone morphogenetic protein-2 and recombinant human beta-nerve growth factor on the healing ofclass III furcation defects in dogs. J Periodontol. 2010;81:1289–98.
Yang S, Cheng J, Man C, Jiang L, Long G, Zhao W, et al. Effects of exogenous nerve growth factor on the expression of BMP-9 and VEGF in the healing of rabbit mandible fracture with local nerve injury. J Orthop Surg Res. 2021;16:74.
Rivera KO, Russo F, Boileau RM, Tomlinson RE, Miclau T, Marcucio RS, et al. Local injections of β-NGF accelerates endochondral fracture repair by promoting cartilage to bone conversion. Sci Rep. 2020;10:22241.
Xu J, Li Z, Tower RJ, Negri S, Wang Y, Meyers CA, et al. NGF-p75 signaling coordinates skeletal cell migration during bone repair. Sci Adv. 2022;8:eabl5716.
Johnstone MR, Brady RD, Schuijers JA, Church JE, Orr D, Quinn JMW, et al. The selective TrkA agonist, gambogic amide, promotes osteoblastic differentiation and improves fracture healing in mice. J Musculoskelet Neuronal Interact. 2019;19:94–103.
Takeda K, Shiba H, Mizuno N, Hasegawa N, Mouri Y, Hirachi A, et al. Brain-derived neurotrophic factor enhances periodontal tissue regeneration. Tissue Eng. 2005;11:1618–29.
Takeda K, Sakai N, Shiba H, Nagahara T, Fujita T, Kajiya M, et al. Characteristics of high-molecular-weight hyaluronic acid as a brain-derived neurotrophic factor scaffold in periodontal tissue regeneration. Tissue Eng Part A. 2011;17:955–67.
Li Y, Yang L, He S, Hu J. The effect of semaphorin 3A on fracture healing in osteoporotic rats. J Orthop Sci. 2015;20:1114–21.
Jimbo R, Singer J, Tovar N, Marin C, Neiva R, Bonfante EA, et al. Regeneration of the cementum and periodontal ligament using local BDNF delivery in class II furcation defects. J Biomed Mater Res. 2018;106:1611–7.
Ramalho I, Bergamo E, Lopes A, Medina-Cintrón C, Neiva R, Witek L, et al. Periodontal tissue regeneration using brain-derived neurotrophic factor delivered by collagen sponge. Tissue Eng Part A. 2019;25:1072–83.
Jimbo R, Tovar N, Janal MN, Mousa R, Marin C, Yoo D, et al. The effect of brain-derived neurotrophic factor on periodontal furcation defects. PLoS ONE. 2014;9: e84845.
Shi L, Feng L, Zhu M-L, Yang Z-M, Wu T-Y, Xu J, et al. Vasoactive intestinal peptide stimulates bone marrow-mesenchymal stem cells osteogenesis differentiation by activating Wnt/β-catenin signaling pathway and promotes rat skull defect repair. Stem Cells Dev. 2020;29:655–66.
Ma W, Lyu H, Pandya M, Gopinathan G, Luan X, Diekwisch TGH. Successful application of a galanin-coated scaffold for periodontal regeneration. J Dent Res. 2021;100:1144–52.
Koewler NJ, Freeman KT, Buus RJ, Herrera MB, Jimenez-Andrade JM, Ghilardi JR, et al. Effects of a monoclonal antibody raised against nerve growth factor on skeletal pain and bone healing after fracture of the C57BL/6J mouse femur. J Bone Miner Res. 2007;22:1732–42.
Rapp AE, Kroner J, Baur S, Schmid F, Walmsley A, Mottl H, et al. Analgesia via blockade of NGF/TrkA signaling does not influence fracture healing in mice. J Orthop Res. 2015;33:1235–41.
Boilly B, Faulkner S, Jobling P, Hondermarck H. Nerve dependence: from regeneration to cancer. Cancer Cell. 2017;31:342–54.
Demir IE, Tieftrunk E, Schorn S, Friess H, Ceyhan GO. Nerve growth factor & TrkA as novel therapeutic targets in cancer. Biochim Biophys Acta. 2016;1866:37–50.
Drilon A. TRK inhibitors in TRK fusion-positive cancers. Ann Oncol. 2019;30:viii23-30.
Desai AV, Robinson GW, Gauvain K, Basu EM, Macy ME, Maese L, et al. Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG). Neuro Oncol. 2022;24:1776–89.
Funding
This work was supported by the Rita Levi-Montalcini Postdoctoral Fellowship (MH), an NSF-GRFP award (ALH), and grants from the National Institutes of Health including T32-AR060719 (ACR), P30-AR074992 (ELS), R56-AR081251 (ELS), R01-DK132073 (ELS), R21-DE032420 (ELS), and R01-DE027957 (WLG).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Hassan, M.G., Horenberg, A.L., Coler-Reilly, A. et al. Role of the Peripheral Nervous System in Skeletal Development and Regeneration: Controversies and Clinical Implications. Curr Osteoporos Rep 21, 503–518 (2023). https://doi.org/10.1007/s11914-023-00815-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11914-023-00815-5